AEON Biopharma

About:

AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

Website: https://aeonbiopharma.com

Top Investors: Daewoong Pharmaceutical

Description:

AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is dedicated to developing novel and proprietary treatment paradigms in order to improve patient outcomes and drive increased value for patients, physicians, and payers.

Total Funding Amount:

$45M

Headquarters Location:

Newport Beach, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)aeonbiopharma.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-03-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai